Senescent Fibroblasts Drive Melanoma Progression Through GCP ‐2 Induced CREB Phosphorylation Enhancing Glycolysis
Aging Cell · 2025
DOI: 10.1111/acel.70239 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2025. Verfasst von Abhijit Basu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergic Diseases, University of Ulm, Ulm, Germany. Hauptthemen laut MEDLINE: Glycolysis, Melanoma, Cellular Senescence, Cyclic AMP Response Element-Binding Protein. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung.
Abstract (Originalsprache)
Aging constitutes the largest risk factor for melanoma progression. While a contribution of factors secreted from senescent skin fibroblasts to the progression of melanoma has been proposed, the nature of such factors and subsequent underlying mechanisms remains elusive. Here we show that the chemokine GCP‐2 is excessively released by senescent fibroblasts in vitro and the skin of old melanoma patients. GCP‐2 regulates, via phosphorylation of the transcription factor CREB at serine 133, defense‐, cell cycle control‐, and glycolysis‐enhancing genes in melanoma cell lines. GCP‐2 promotes oncogenic properties in vitro and in vivo in murine melanoma models. Inhibition of CREB phosphorylation in melanoma cells represses glycolytic target genes and induces a switch from glycolysis to oxidative phosphorylation that translates into a significant decline in tumor size in vivo in murine melanoma models. This study identifies a senescent fibroblast to chemokine to CREB to metabolic axis that drives melanoma progression. Targeting this axis may hold promise for novel therapeutic approaches in difficult‐to‐treat melanoma in older adults.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Allergic Diseases, University of Ulm, Ulm, Germany.
- Aging Research Center (ARC), University of Ulm, Ulm, Germany.
- Institute for Genome Stability in Ageing and Disease, Medical Faculty and Cologne Excellence Cluster for Cellular Stress Responses in Ageing-Associated Diseases (CECAD) Research, University of Cologne, Cologne, Germany.
- Helmholtz Diabetes Center & German Diabetes Center (DZD), Helmholtz Zentrum München, Division of Metabolic Diseases, Technische Universität München, Neuherberg, Germany.
- Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.
- Department of Dermatology and Venereology, University of Cologne, Cologne, Germany.
ORCID-Profile: Abhijit Basu, Karmveer Singh, Diana Crisan, Nicolai Treiber, Lars Alexander Schneider, Jennifer I Engelmeyer, Björn Schumacher, Pallab Maity, Daniel Brandt, Martin Jastroch, Cornelia Mauch, Hartmut Geiger, Dimitris Kletsas, Karin Scharffetter-Kochanek
Förderung
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
Zitieren
APA
Basu, A., Farsam, V., Singh, K., Crisan, D., Treiber, N., Schneider, L. A., Huber, M., Engelmeyer, J. I., Schumacher, B., Maity, P., Brandt, D., Jastroch, M., Mauch, C., Geiger, H., Kletsas, D., & Scharffetter-Kochanek, K. (2025). Senescent Fibroblasts Drive Melanoma Progression Through GCP ‐2 Induced CREB Phosphorylation Enhancing Glycolysis. Aging Cell. https://doi.org/10.1111/acel.70239
Vancouver
Basu A, Farsam V, Singh K, Crisan D, Treiber N, Schneider LA, et al. Senescent Fibroblasts Drive Melanoma Progression Through GCP ‐2 Induced CREB Phosphorylation Enhancing Glycolysis. Aging Cell. 2025. doi:10.1111/acel.70239
BibTeX
@article{Basu2025,
author = {Basu, Abhijit and Farsam, Vida and Singh, Karmveer and Crisan, Diana and Treiber, Nicolai and Schneider, Lars Alexander and Huber, Margit and Engelmeyer, Jennifer I and Schumacher, Björn and Maity, Pallab and Brandt, Daniel and Jastroch, Martin and Mauch, Cornelia and Geiger, Hartmut and Kletsas, Dimitris and Scharffetter-Kochanek, Karin},
title = {Senescent Fibroblasts Drive Melanoma Progression Through GCP ‐2 Induced CREB Phosphorylation Enhancing Glycolysis},
journal = {Aging Cell},
year = {2025},
doi = {10.1111/acel.70239}
}
EUVIMED